Human stool transplant shows the way for treating colon germ

The human stool or feces have now become an antidote for the patients who are hit hard by the bacterium Clostridium difficile also called the C. diff bacterium. Even though, the illness from C. diff commonly affects older adults in hospitals or long-term care facilities. It is estimated that about three million Americans are infected annually with this bacterium. Most people have no symptoms but about 500,000 or more than half of them aged 65 or older develop abdominal cramps, diarrhea, fever and inflamed colons due to this bacterium.

As many as thirty thousand Americans die each year from the C. diff bacterium usually after recurrences of infection. The infection is due to the result of taking antibiotics that wipe out the friendly bacteria in the colon that usually keeps the C. diff bacterium under control or at bay. Once established the C. diff bacterium can produce toxins that attack the lining of the intestine and toxins destroy healthy cells, produce inflammatory cells and decaying cellular debris inside the colon.

Various treatment procedures involve usage or taking of drugs and vaccines manufactured by drug manufacturers such as Merck & Co and Sanofi. However, the growing numbers of gastroenterologists are excited and placing their bets on the human stool or fecal transplants. The human stool transplant in an experimental setting has consistently cured about 85 to 90 percent of patients who have multiple episodes of C. diff.


Switch to our mobile site